Prospective trial of ossein-hydroxyapatite compound in surgically induced postmenopausal women
- 1 January 1989
- Vol. 10 (3) , 179-185
- https://doi.org/10.1016/8756-3282(89)90051-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Postmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with CalciumAnnals of Internal Medicine, 1987
- The role of skeletal calcium deficiency in postmenopausal osteoporosisCalcified Tissue International, 1986
- Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitisPostgraduate Medical Journal, 1985
- Linear one-step assay for the determination of orthophosphateAnalytical Biochemistry, 1983
- Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosisThe American Journal of Clinical Nutrition, 1982
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982
- PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMENThe Lancet, 1980
- The Relation between Plasma Androstenedione, Plasma Oestrone and Androstenedione to Oestrone Conversion Rates in Postmenopausal Women with and without FracturesClinical Science, 1978
- MENOPAUSAL CHANGES IN CALCIUM BALANCE PERFORMANCE1978
- Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal WomenAnnals of Internal Medicine, 1977